Oncology Pharma Inc.

ONPH · OTC
Analyze with AI
12/31/2022
9/30/2022
6/30/2022
12/31/2004
Operating Activities
Net Income-$255-$5,319-$24-$81
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$22$100$41$0
Other Non-Cash$230$5,216$0$0
Operating Cash Flow-$2-$4$17-$81
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$20$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$20$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$4$0$122
Financing Cash Flow$1$4$0$122
Forex Effect$0$0$0$0
Net Chg. in Cash-$1$1-$3$41
Supplemental Information
Beg. Cash$2$1$4$2
End Cash$0$2$1$43
Free Cash Flow-$2-$4$17-$81